ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,830,000 | -29.8% | 70,000 | 0.0% | 0.61% | -21.9% |
| Q2 2015 | $4,029,000 | -9.6% | 70,000 | 0.0% | 0.78% | -8.9% |
| Q1 2015 | $4,457,000 | +3.1% | 70,000 | 0.0% | 0.86% | +2.0% |
| Q4 2014 | $4,322,000 | +59.0% | 70,000 | 0.0% | 0.84% | +52.6% |
| Q3 2014 | $2,718,000 | +12.7% | 70,000 | 0.0% | 0.55% | +15.9% |
| Q2 2014 | $2,412,000 | +179.2% | 70,000 | +250.0% | 0.48% | +168.0% |
| Q1 2014 | $864,000 | – | 20,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |